# Newton Biocapital Partners

Newton Biocapital Partners is a Private Equity based in Brussels, Belgium.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Brussels, Belgium
- **Region:** Europe
- **Address:** Avenue de Tervueren 273, 1150 Brussels, Belgium
- **Founded:** 2017
- **Assets under management:** Undisclosed
- **Website:** www.newtonbiocapital.com
- **LinkedIn:** https://www.linkedin.com/company/newton-biocapital-fund

## Regulatory record

- **Reports private funds:** No

## About

Newton Biocapital is a life sciences investment firm leveraging innovation in Europe and Japan. Its mission is to mature innovation and support the growth of portfolio companies to create value for patients, society, local ecosystems, and investors. The firm invests in early-stage companies in both regions, focusing on solutions for chronic health conditions, and participates proactively as board members.

## Sectors

- Digital Health
- Medical Devices
- DNA/RNA Therapeutics
- Oncology
- Neurological Diseases
- Metabolic Diseases
- Autoimmune Diseases
- Genetic Diseases
- Antibody Therapeutics
- Small Molecules

## Offices

- Tokyo, Japan

## People

- Alain Parthoens — Chief Executive Officer
- Sadashi Suzuki — Japan Representative
- Guy Heynen — Chief Medical and Regulatory Officer
- Michihiko Wada — Chief Regulatory and Development Officer
- Danny Gonnissen — Chief Operating Officer
- Pierre Detrixhe — Venture Director
- Tomoko Asaoka — Scientific Director
- Dario Padovani — Chief Financial Officer
- Daisuke Morishita — Venture Partner
- Goro Takeda — Founder

## Related profiles

- [Newtiming Investment](https://altss.com/profile/newtiming-investment)
- [Newton Foundation](https://altss.com/profile/newton-foundation)

---

Last updated: 2026-08-11T15:07:34.613Z

Canonical page: https://altss.com/profile/newton-biocapital-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology